Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Change in Account Payables: 2019-2023

Historic Change in Account Payables for Relay Therapeutics (RLAY) over the last 5 years, with Dec 2023 value amounting to -$2.4 million.

  • Relay Therapeutics' Change in Account Payables fell 251.88% to -$4.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$6.4 million, marking a year-over-year decrease of 228.70%. This contributed to the annual value of -$2.4 million for FY2023, which is 220.36% down from last year.
  • Relay Therapeutics' Change in Account Payables amounted to -$2.4 million in FY2023, which was down 220.36% from $2.0 million recorded in FY2022.
  • In the past 5 years, Relay Therapeutics' Change in Account Payables ranged from a high of $3.0 million in FY2019 and a low of -$2.4 million during FY2023.
  • For the 3-year period, Relay Therapeutics' Change in Account Payables averaged around $175,000, with its median value being $930,000 (2021).
  • Its Change in Account Payables has fluctuated over the past 5 years, first skyrocketed by 326.83% in 2021, then slumped by 220.36% in 2023.
  • Relay Therapeutics' Change in Account Payables (Yearly) stood at $3.0 million in 2019, then slumped by 113.67% to -$410,000 in 2020, then spiked by 326.83% to $930,000 in 2021, then soared by 113.87% to $2.0 million in 2022, then slumped by 220.36% to -$2.4 million in 2023.